These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26440042)

  • 1. Insulin-like growth factor I and risk of incident cancer in elderly men - results from MrOS (Osteoporotic Fractures in Men) in Sweden.
    Carlzon D; Svensson J; Petzold M; Karlsson MK; Ljunggren Ö; Haghsheno MA; Damber JE; Mellström D; Ohlsson C
    Clin Endocrinol (Oxf); 2016 May; 84(5):764-70. PubMed ID: 26440042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both low and high serum IGF-I levels associate with cancer mortality in older men.
    Svensson J; Carlzon D; Petzold M; Karlsson MK; Ljunggren Ö; Tivesten A; Mellström D; Ohlsson C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4623-30. PubMed ID: 23015658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study.
    Ohlsson C; Mellström D; Carlzon D; Orwoll E; Ljunggren O; Karlsson MK; Vandenput L
    J Bone Miner Res; 2011 Apr; 26(4):865-72. PubMed ID: 21433071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men.
    Carlzon D; Svensson J; Petzold M; Karlsson MK; Ljunggren Ö; Tivesten Å; Mellström D; Ohlsson C
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2308-16. PubMed ID: 25057875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study.
    van Bunderen CC; van Nieuwpoort IC; van Schoor NM; Deeg DJ; Lips P; Drent ML
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4616-24. PubMed ID: 20610588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum adiponectin predicts incident fractures in elderly men: Osteoporotic fractures in men (MrOS) Sweden.
    Johansson H; Odén A; Lerner UH; Jutberger H; Lorentzon M; Barrett-Connor E; Karlsson MK; Ljunggren O; Smith U; McCloskey E; Kanis JA; Ohlsson C; Mellström D
    J Bone Miner Res; 2012 Jun; 27(6):1390-6. PubMed ID: 22407876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
    Janssen JA; Wildhagen MF; Ito K; Blijenberg BG; Van Schaik RH; Roobol MJ; Pols HA; Lamberts SW; Schröder FH
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4391-6. PubMed ID: 15356036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP-1 predicts all-cause mortality in elderly women independently of IGF-I.
    Nolte AA; Movin M; Lundin H; Salminen H
    Growth Horm IGF Res; 2015 Dec; 25(6):281-5. PubMed ID: 26380917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.
    Qian F; Huo D
    Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2332-2342. PubMed ID: 32856611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
    J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.
    Finne P; Auvinen A; Koistinen H; Zhang WM; Määttänen L; Rannikko S; Tammela T; Seppälä M; Hakama M; Stenman UH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2744-7. PubMed ID: 10946875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age.
    Eriksson M; Wedel H; Wallander MA; Krakau I; Hugosson J; Carlsson S; Svärdsudd K
    Prostate; 2007 Aug; 67(11):1247-54. PubMed ID: 17570499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Chia D; Crawford ED; Kaaks R; Hayes RB
    Int J Cancer; 2007 Nov; 121(10):2267-73. PubMed ID: 17597108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.